ADIM
CMA

Alpha DNA Investment Management’s Comerica CMA Stock Holding History

Alpha DNA Investment Management’s Portfolio CMA Stock Details CMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7,284
Closed -$517K – 156
2022
Q3 		$517K Buy
+7,284
New +$574K 0.43% 124

Other funds holding CMA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Alpha DNA Investment Management's CMA Position: Q4 2022 in Review

Alpha DNA Investment Management sold out of Comerica (CMA) in Q4 2022, closing a stake of 7,284 shares — an estimated $517K sold.

Alpha DNA Investment Management first reported a position in CMA in Q3 2022 and held it in 1 quarter. The position peaked at $517K in Q3 2022. 569 funds tracked by Wall St. Rank hold CMA as of Q4 2022.

  • Alpha DNA Investment Management reported no remaining Comerica position as of Q4 2022 after selling out during the quarter.
  • Alpha DNA Investment Management sold 7,284 Comerica shares in Q4 2022, an estimated $517K.
  • Alpha DNA Investment Management first reported a position in Comerica in Q3 2022 and held it in 1 quarter.
  • Alpha DNA Investment Management's Comerica position peaked at $517K in Q3 2022.
  • 569 funds tracked by Wall St. Rank held Comerica as of Q4 2022.

Based on Alpha DNA Investment Management's 13F filing for Q4 2022, filed 27 Jan 2023.